Harris Pastides, who is retiring next summer after 10 years as president of the University of South Carolina, is the new chair of the board of directors for the S.C. Institute of Medicine and Public Health, which provides guidance on state public health policy.
Pastides' two-year term begins Jan. 1.
“South Carolina continues to face persistent and emerging health challenges while the health care and public health systems are adapting to new technologies and payment models,” Pastides said in a news release. “IMPH is uniquely situated to share nonpartisan, evidence-based policy solutions, and I look forward to advancing these matters of importance for all South Carolinians.”
The nonprofit institute also named Joel A. Smith III, dean emeritus of USC’s Darla Moore School of Business, as its board vice chair for a second term.
Lou Kennedy, president and CEO of Nephron Pharmaceuticals Corp., is joining the board for the first time for the 2019-2021 term. David Cole, president of the Medical University of South Carolina, and Richard Wilkerson, retired president of Michelin North America, were elected to the board for renewed terms.
The institute also announced that Maya Pack and Megan Weis will become co-directors of the organization on Jan. 1.
Pack, who will serve as associate executive director, will lead the institute’s business and financial management and manage all its programs and contracts. Weis will serve as senior director of strategic engagement, building and expanding the organization’s communications and development work.